Alejandro Aballay, Pharm.D., Ph.D., a national leader in immune signaling and graduate education, has been named dean of the MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, effective Jan. 2, 2024.
Tissue-sparing treatments using focal therapy, aimed to avoid side effects like urinary incontinence, are becoming available for prostate cancer patients like Morton McPhail of Texas.
The implementation of artificial intelligence-powered large vessel occlusion (LVO) detection software for acute stroke triage can improve endovascular thrombectomy treatment times, according to new research from UTHealth Houston.
R.Á.P.I.D.O., a culturally relevant acronym created under the leadership of Jennifer Beauchamp, PhD, RN, at Cizik School of Nursing at UTHealth Houston to raise awareness of stroke signs in the Spanish-speaking Hispanic/Latino community and save lives, has been adopted by the American Stroke Association (ASA), the organization announced today.
Unruptured cerebral aneurysms of sizes and locations that require attention may be frequently missed in routine clinical care, but a machine learning algorithm could minimize missed care opportunities, according to a new study from UTHealth Houston.
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.
After a rare view inside the world of professional sports and orthopedic medicine through a clinical rotation with the Houston Texans this summer, Analisa Narro, a fourth-year student with McGovern Medical School at UTHealth Houston, brought back key lessons from the enriching experience.
Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.
A five-year, $3.1 million grant to study preventive strategies for sudden unexpected death in epilepsy (SUDEP) has been awarded to UTHealth Houston by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke.
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centers, women with large vessel occlusion acute ischemic stroke are less likely to be routed to the centers compared to men, according to a new study from UTHealth Houston.
The FDA is being asked to investigate the popular energy drink, PRIME, which contains elevated levels of caffeine equivalent to 6 cans of coke. John Higgins, MD, energy drink researcher and cardiologist with UTHealth Houston is availble for interviews to discuss the…
Versil Joyles-Stapleton, 76, can’t seem to slow herself down — a drastic change to how she lived her life just 2 years ago.
The FDA has granted Priority Review to the anti-Alzheimer’s drug Leqembi for the traditional approval application, with required action from the agency by July 6, 2023. Paul E. Schulz, MD, professor of neurology and director of the Neurocognitive Disorders Center with McGovern…
Children and teenagers who volunteer tend to flourish mentally and physically, according to a new study from UTHealth Houston.
Nearly $13 million in federal grant funds to study treatments for traumatic brain injury, which kills an average of 190 people and hospitalizes another 600 in the U.S. every day, has been awarded to UTHealth Houston by the Department of Defense’s Office of Congressionally Directed Medical Research Programs (CDMRP).
UTHealth Houston pediatric dentists are now part of the Integrated Health Clinic, a program of Harris County Resources for Children and Adults, by providing comprehensive medical, dental, and behavioral health care for children in Harris County who are involved or under the care of Child Protective Services.
The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington’s disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
When a person reads a sentence, two distinct networks in the brain are activated, working together to integrate the meanings of the individual words to obtain more complex, higher-order meaning, according to a study at UTHealth Houston.
The presence of a misfolded alpha-synuclein protein can be used to determine if people have Parkinson’s disease, according to a new study using technology developed by a researcher at UTHealth Houston. This biomarker could pave the way for the development of better diagnostic tools and new treatment options for the disease.
The new UTHealth Houston School of Behavioral Health Sciences has been approved by the Texas Higher Education Coordinating Board and unanimously by The University of Texas System Board of Regents, moving the university closer to establishing a seventh school.
Paul E. Schulz, MD, neurologist with UTHealth Houston and Memorial Hermann, is available over the next few days to comment on recent news that the Veterans Health Administration will provide coverage for Leqembi, which recently received accelerated approval from the…
Prenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase risk of colorectal cancer in adult offspring, according to a study by researchers at UTHealth Houston.
Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from happening, according to new research from UTHealth Houston.
The evidence does not support the common belief that indwelling catheters cause more urinary tract infections (UTIs) than intermittent catheterization, according to a systematic review of bladder management and infection risk from UTHealth Houston.
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed and were linked to Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health published today in the Journal of Infectious Diseases.
Deanna Hoelscher, PhD, John P. McGovern Professor in Health Promotion and campus dean of UTHealth Houston School of Public Health in Austin, has been appointed to the 2025 Dietary Guidelines Advisory Committee. The Committee will be tasked with reviewing the current body of science on key nutrition topics and developing a scientific report that includes its independent assessment of the evidence and recommendations for the U.S. Department of Health and Human Services and U.S. Food and Drug Administration as they develop the Dietary Guidelines for Americans (the Guidelines).
School garden-based interventions can improve metabolic parameters such as blood sugar and cholesterol in children, according to a new study from UTHealth Houston.
After hundreds of thousands of miles and 20 years of service, UTHealth Houston School of Dentistry has a new set of wheels for its Mobile Dental Van program to continue providing care to underserved communities.
A five-year, nearly $3.5 million grant to study the mechanisms of brain receptors involved in neurological disorders such as learning disabilities has been awarded to Vasanthi Jayaraman, PhD, of UTHealth Houston by the National Institutes of Health.
A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from UTHealth Houston Heart & Vascular.
Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
Older adults residing in assisted living facilities and quarantined to their rooms during the height of the COVID-19 pandemic lost significant weight, according to gerontology care providers and researchers from McGovern Medical School at UTHealth Houston.
Research shows that incidences of Kaposi’s sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.
In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
A substantial proportion of ethnically diverse children from low-resource backgrounds with severe COVID-19 illness are reporting long-term complications from the virus, according to research from UTHealth Houston.
A method that combines case investigation data from local health departments and hospitalizations records from local institutions allows for the objective detection of new waves of infection during a pandemic, according to research from UTHealth Houston.
Populations in U.S. counties defined as more vulnerable based on social factors including socioeconomic status and racial/ethnic minority status were significantly less likely to receive timely breast, cervical, and colorectal cancer screenings, according to research from UTHealth Houston.
Imagine having to drink a solution of cornstarch and water every four hours to survive, and that missing a dose, even by 15 minutes, could lead to seizures and death. This is the reality for Rebecca Tarrence, who has glycogen storage disease type 1a (GSDIa), a rare genetic disease caused by the presence of two genetic changes on the same gene affecting glucose production.
Insecure income associated with nontraditional employment known as “gig work” has a negative impact on the overall health and well-being of U.S. workers, according to a new article by researchers from UTHealth Houston.
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
People who are genetically at higher risk for stroke can lower that risk by as much as 43% by adopting a healthy cardiovascular lifestyle, according to new research led by UTHealth Houston, which was published today in the Journal of the American Heart Association.
A novel, disease-modifying therapy for Alzheimer’s disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice, according to a new study from UTHealth Houston.
Elisabeth Gentry had experienced auras ever since she was a toddler, but she didn’t learn that the occasional strange tastes in her mouth and feelings of impending doom were epilepsy until 2015, when she was 15 years old and suffered a grand mal seizure.
A large multicenter, randomized clinical trial revealed no difference in the risk of endotracheal intubation requirement at 30 days between awake prone positioning and standard positioning for patients with COVID-19 who suffered from acute hypoxemic respiratory failure, according to research published in JAMA by researchers at UTHealth Houston.
Younger adults living in the U.S. are less likely to be screened for colorectal cancer than older U.S. adults, despite now being eligible under new screening guidelines, and face greater disparities than older U.S. adults who are eligible for screening, according to research from UTHealth Houston.
People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston.
Anne Briggs always longed to be a mom.
But after having no menstrual cycle for over a decade, she knew when she married her husband Mark in 2020 that conceiving a child naturally would be unlikely.
Patients diagnosed with cancer more than one year ago and those not receiving active treatment were no more vulnerable to worse COVID-19 outcomes than patients without cancer, according to a new study led by UTHealth Houston.
UTHealth Houston’s Movement Disorders and Neurodegenerative Diseases Fellowship Training Program (UTMOVE fellowship program) has been chosen by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) as one of eight international academic centers to train a new movement disorder clinician-researcher — a neurologist with additional training and expertise in diagnosing and treating Parkinson’s and related diseases — as part of the Edmond J. Safra Fellowship in Movement Disorders Class of 2025.
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.